Propel Bio Management, LLC / FULC
Propel Bio Management, LLC’s Fulcrum Therapeutics Inc Position
Does Propel Bio Management, LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 750.0K shares worth $5M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q2 2024
Shares
750.0K
% of Portfolio
+3.02%
Quarters Held
3
position exited
Position History FULC
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of FULC.